Forum-Institut für Management conference "Drug regulation and drug care in 2021" provides a timely opportunity to discuss the latest change in the HTA and pricing AMNOG procedure and drug regulation in German statutory health insurance. It also addresses the current measures to safeguard the supply of medicines.
Ask for a Free trial and get access to the latest stories
- Health Care
- Market Access
- HTA – policies & practices
- European medicine regulations
- Drug safety issues
- Pricing & Reimbursement
- International medicines agencies
If you are a Payer, Pharmaceutical or Consulting professional our premium data will keep you informed on the regulatory, pricing, market access and cost-effectiveness issues that impact all stakeholders.
an initial 10 day temporary access of APM Health Europe.